Bisphenol A (BPA) is used in various areas of daily life as a major component of plastic products. However, it is also known as a strong endocrine disruptor that affects the human immune system. Studies have indicated that BPA possibly exacerbates allergic diseases such as atopic dermatitis and asthma. The main aim of this study was to elucidate whether BPA is directly involved in the exacerbation of allergic inflammation. Initially, in vivo experiments with mouse models of allergic inflammation induced by Th2 type hapten toluene-2, 4-diisocyanate (TDI) was performed. Mice were subjected to oral administration of BPA 48, 24, and 4 h before challenge with TDI. Dermal challenge of TDI onto the ear auricle was performed for the allergic dermatitis model, and intratracheal challenge of TDI was performed for the allergic airway inflammation model. In the allergic dermatitis model, ear-swelling response was significantly downregulated by high doses of BPA. The opposite reaction was observed in the allergic airway inflammation model, including significant exacerbation of red coloration in the lung, local cytokine levels, and total IgE levels in serum by BPA administration. To confirm the in vivo results, in vitro experiments with human epidermal keratinocytes (HEKs) and bronchial epithelial (BEAS-2B) cells were carried out. Significant enhancement of cytokine release from BEAS-2B cells but not HEKs in the BPA-treated group supported the in vivo observations. Our results imply that exposure to BPA directly exacerbates allergic airway inflammation but not allergic dermatitis.
Bisphenol A (BPA) is used in various areas of daily life as a major component of plastic products including epoxy resin containers, dental sealants, carbonless copy, and as a precursor in flame retardants (Liao and Kannan, 2011; Lopez-Cervantes and Paseiro-Losada, 2003; Suzuki et al., 2000) . However, persistent organic pollutant contamination of BPA has become an important public concern recently as BPA has serious toxic effects on human health and wildlife (Huang et al., 2012) . In particular, BPA is recognized as a representative endocrine-disrupting substance that alters the reproductive system (Karnam et al., 2015; Peretz et al., 2014) . Studies have indicated that BPA induces immunosuppression with consequences such as apoptosis in thymocytes (Rochester, 2013) . It has also been shown that BPA could possibly exacerbate allergic diseases such as allergic dermatitis, rhinitis, and allergic asthma. Bauer et al. (2012) reported that when pregnant mice were exposed to BPA, enhanced airway lymphocytic and lung inflammation was observed in adult offspring. In humans, Gascon et al. (2015) showed that increasing concentrations of maternal urinary BPA are correlated with an increasing risk of asthma symptoms and respiratory tract infection in children. Zhou et al. (2017) also focused on the human data and found the evidence which mothers of infants with allergic diseases had significantly higher urinary BPA levels than those of infants without allergic diseases. This finding indicates that, increased risk of infant allergic diseases is possibly associated with creatinine-adjusted maternal urinary BPA concentrations. However, above mentioned studies have only focused the indirect effects of BPA on inflammatory diseases by prenatal exposure, and the events between administration and outcome remain quite uncertain. He et al. (2016) demonstrated that simultaneous exposure to BPA and ovalbumin enhanced lung eosinophilia by promotingTh2-type immune response in adult male mice and Kim et al. (2017) suggested that exposure to phthalates and concentration of BPA in urine sample is associated with aggravation of AD symptoms in children. However, little is known about the detail mechanisms.
Interestingly, there are also opponents to the abovementioned preclinical and clinical reports. Nygaard et al. (2015) disclaimed the relationship between BPA administration and development of allergy at exposure levels relevant for humans. They showed that early-life exposure to BPA modestly augmented allergic responses in a mouse model of airway allergy only at high BPA dose (100 lg/ml/day), and not in mouse models for food-allergy and tolerance. Thus, it remains unclear whether exposure to BPA definitely exacerbates allergic reaction, and the detailed mechanisms of action are unexplored.
Therefore, the main aim of this study was to elucidate whether BPA is directly involved in the exacerbation of allergic inflammation. In order to confirm this, in vivo experiments with mouse models of allergic dermatitis and allergic airway inflammation were initially conducted. In vitro experiments using a human keratinocyte cell line, a human bronchial epithelial cell line, and mouse bone marrow-derived dendritic cells (BMDCs), as well as mixed leukocyte reaction assay were additionally performed to confirm the detail mechanisms of action. Epithelial cells including keratinocytes and bronchial epithelial cells play important roles in the development of local allergic inflammation by secretion of cytokines such as thymic stromal lymphopoietin (TSLP) (Mitchell and O'Byrne, 2017; Wilson et al., 2013) . Antigen-presenting cells including DCs are also contributors to allergic inflammation by recognizing exogenous allergens and transferring information to helper T-cells (Guermonprez et al., 2002; Polte et al., 2015) .
MATERIALS AND METHODS
Experimental animals. Seven-week-old both sexes of BALB/cAnN and female C57BL/6J mice were purchased from Charles River Laboratories Japan, Inc. (Kanagawa, Japan) and housed in groups of fewer than 5 mice per cage under controlled lighting (a 12-h light-dark cycle), temperature (22 C 6 3 C), humidity (55% 6 15%), and ventilation (at least 10 complete fresh-air changes per hour). Standard rodent diet (Certified Pellet Diet MF; Oriental Yeast Co., Tokyo, Japan) and local tap water were provided ad libitum. TDI-induced allergic inflammation model. For the in vivo model of inflammation, male BALB/c mice were sensitized and challenged with TDI, which is a type 2 helper T-cells (TH2 cells)-dominated hapten, according to a previous study (Fukuyama et al., 2015) .
To exclude the effects of the estrus cycle and endogenous estrogen, male mice were used to generate the model in this study. The abdominal skin of the mice was depilated with a commercially available depilating cream one day before the first sensitization. Immediately before the first sensitization, the horny layers of the depilated skin were stripped off ten times with adhesive tape. Subsequently, 50 ll of 5% TDI solution in acetone was applied to the stripped epidermis (day 1). The same procedure was performed at the same site without tape stripping on days 2 and 3. Three weeks after the first sensitization, the allergic reaction was boosted by the application of 50 ml of 0.5% TDI onto the depilated abdominal skin.
BPA administration in TDI-induced allergic contact dermatitis model. Five days after the final sensitization of TDI, TDI-sensitized male BALB/c mice were subjected to oral administration of the vehicle at a concentration of 0.06 or 0.2 mg/kg BPA 48, 24, and 4 h before topical challenge of TDI (0.5%) onto the shaved rostral part of the neck (30 ll) and left ear auricle (20 ll). The doses of BPA used in this study were selected based on previous reports to avoid systemic toxicity or excessive immune suppression (Bauer et al., 2012) . To measure the itching behavior, the mice were video-monitored for 1 h and scratching bouts (directed against the neck and ear regions) were determined directly after TDI challenge. For the ear swelling test used to evaluate the dermal inflammation potential, the thickness of the left ear was measured before and 24 h after TDI challenge. Swelling was calculated by comparing the ear thickness (cutimeter, Mitutoyo Corporation., Tokyo, Japan) before and 24 h after challenge. Right after measuring the 24-h postTDI ear thickness, mice were euthanized by exsanguination from the abdominal aorta and posterior vena cava under anesthesia by isoflurane inhalation. Blood samples were taken from the inferior vena cava, and serum samples were assayed for IgE levels. The left ear auricle was removed from each mouse and stored until use for cytokine evaluation. Single-cell suspensions were prepared from the auricular lymph node (LN) removed from each mouse by passage through a sterile 70-lm nylon cell strainer in 1 ml of RPMI 1640 supplemented with 5% FBS. Single-cell suspensions were used in fluorescence-activated cell sorting (FACS) and cytokine evaluation.
Chemical administration in TDI-induced allergic airway inflammation model. Five days after the final sensitization of TDI, oral administration of BPA to TDI-sensitized male BALB/c mice was performed with the same doses of BPA as those in the contact dermatitis model 48, 24, and 4 h before intratracheal challenge of TDI (0.001%, 50 ll). Twenty-four hours after TDI challenge, mice were euthanized by exsanguination from the abdominal aorta and posterior vena cava under isoflurane anesthesia. The red coloration in the lung was evaluated by a semi-quantitative score based on the criteria described in previous study (Nishino et al., 2016) (0 ¼ no visible changes, 1 ¼ diffuse or patchy red coloration, 2 ¼ moderate dispersed red coloration, 3 ¼ severe red coloration). Blood samples, the vice lobe of the lung, bronchoalveolar lavage fluid (BALF), and hilar LNs were isolated from each mouse for total IgE level measurement, cytokine evaluation, and FACS analysis. BALF was collected by cannulating the trachea and lavaging the lungs three times with 1 ml of PBS supplemented with 1% FBS. The supernatants from the first BALF fraction were stored for cytokine evaluation. The cell pellets of all three fractions were resuspended, pooled, and used for differential cell counts by FACS. IgE measurements in serum. Total IgE levels in the serum were measured by ELISA using Mouse IgE Ready-SET-Go according to the manufacturer's protocol. Briefly, each flat-bottomed microplate well was coated with capture antibody in PBS and incubated overnight at 4 C. The content of each well was removed and the plate was washed with wash buffer. Nonspecific binding was blocked by incubation with 1% bovine serum albumin in PBS for 2 h at room temperature. The diluted serum was added to each well and incubated for 2 h at room temperature. Detection antibody (mixture of biotin-conjugated rat antimouse IgE monoclonal antibody and streptavidin-horseradish peroxidase conjugate) was added to each well and incubated for another 1 h at room temperature. The plate was developed with TMB in the dark, at room temperature, for 30 min. Optical density was read at a wavelength of 450 nm with a with a microplate reader.
Evaluation of cytokines in ear and lung tissues. Ear and lung tissues were frozen in dry ice and stored at À80 C until use. Cytokines in tissues were evaluated according to Fukuyama et al. (2015) . The protein content was determined with the DC protein assay kit. Levels of IL-1b, -4, -33, IFNc, TNFa, and TSLP were measured by ELISA. Recently investigated reports (Cruse et al., 2016; Fukuyama, et al., 2015; Stover et al., 2016) demonstrated that secretions of IL-1b, IL-6, KC, TARC and TNFa were detected in the same TDI-induced allergic inflammation model, although they were not TH2 dominated cytokines. In addition, Nishino et al. (2016) showed that similar TH2-dominated hapten, trimellitic anhydride, also upregulated the secretions of TH1, TH9, and TH17 type cytokines apart from TH2 type cytokines. Therefore, in this study, we measured not only the TH2 type cytokines such as IL-4 but also other types of cytokines including IL-1b, -33, IFNc, TNFa, and TSLP which play an important role to maintain the allergic response.
Human keratinocyte and bronchial epithelial cell line culture. Human epidermal keratinocytes (HEKs) and bronchial epithelial (BEAS-2B) cells were cultured following the standard protocol with EpiVita basal medium and BEGM Bronchial Epithelial Cell Growth media, respectively, and incubated at 37 C in 5% CO 2 and 100% humidity. Cells (1 Â 10 4 cells/200 ll) at 70% confluency were seeded into 96-well culture plates and preexposed for 24 h to BPA at 1, 10, or 100 nmol/l followed by exposure to the tolllike receptor 3 ligand poly (I:C) (2 lg/ml) for another 24 h. BPA at high concentrations (100 nmol/l) did not induce any cell toxicity. After exposure, the production of TNFa and IL-8 in supernatants was evaluated by ELISA. In another setting, TSLP gene expression in cell pellets was semiquantified by reverse transcriptase polymerase chain reaction. Three independent experiments were performed in different settings.
Preparation of bone marrow-derived DCs and cytokine assay. BMDCs were generated from bone marrow cells of female BALB/c mice, as described previously in Fukuyama et al. (2015) . At day 8, nonadherent and loosely adherent cells were isolated and seeded at 5 Â 10 4 cells/200 ll into 96-well plates. The cells were preexposed for 24 h to BPA at 1, 10, or 100 nmol/l followed by exposure to the toll-like receptor 2 ligand LPS (25 ng/ml) for another 24 h. The high concentrations of each chemical (100 nmol/l) did not induce any cell toxicity. After exposure, cytokine production (IL-12) in BMDCs was evaluated by ELISA. Three independent experiments were performed in DCs from different animals.
Mixed leukocyte reaction assay. Mixed leukocyte reaction assay was conducted according to previous studies (Beyer et al., 2004; Stover et al., 2016) with slight modifications. High-purity BMDCs from female BALB/c mice were generated and treated with the same doses of BPA as mentioned in the BMDC cytokine assay. A mycophenolic acid solution at 10 lmol/l was used as a positive control. To initiate the mixed leukocyte reaction, T-cells were isolated from the spleen of female C57BL/6 mice. Single-cell suspensions were prepared from the spleen by passage through a sterile 70-lm nylon cell strainer in 1 ml of culture medium (RPMI 1640 with L-glutamine, 100 U/ml penicillin, 100 lg/ml streptomycin, and 10% heat-inactivated FBS). The spleen cells were then incubated in an erythrocyte lysis buffer for 5 min, followed by an enrichment of T-lymphocytes achieved using Mouse T Lymphocyte Enrichment Set-DM. This leads to a T-cell purity of higher than 90%. Enriched T-cells (1 Â 10 6 cells/tube) and BPA-treated BMDCs (1 Â10 5 cells/tube) were seeded in a 2-ml tube and incubated for 5 additional days.
were washed twice with PBS, resuspended with 5% trichloroacetic acid, and stored at 4 C for 18 h. Cell pellets were resuspended in 0.5 ml of trichloroacetic acid and transferred to scintillation vials containing 4.5 ml of scintillation fluid. T-cell proliferation (DPM, disintegrations per minute) was determined using a liquid scintillation counter.
Statistical analysis. Statistical significance of the difference between the vehicle control and treated groups was estimated at 5% and 1% levels of probability. Data from the vehicle-only control and the BPA-treated groups were evaluated by Bartlett's test for equality of variance. When group variances were homogeneous, a parametric 1-way analysis of variance was conducted to determine statistical differences among groups. When the analysis of variance was significant, Dunnett's multiple comparison test was applied. When group variances were heterogeneous, data were evaluated by Kruskal-Wallis nonparametric analysis of variance. When differences were significant, Dunnett's mean rank-sum test was applied. Data are expressed as mean 6 SEM. The data were analyzed using Prism 4 (GraphPad Software, San Diego, California).
RESULTS

Administration of BPA Slightly Reduced Inflammatory and Itch Responses in Mouse Model of Allergic Dermatitis
When mice with allergic dermatitis were exposed to BPA before the final TDI challenge, their skin inflammation (ear swelling response) was dose-dependently reduced when compared with the mice in the vehicle control group, and significant change was observed in highest concentration group ( Figure 1A ). Corresponding reduction of scratching bouts to ear swelling response was seen in the BPA-administered group ( Figure 1B) . The reduced ear swelling and scratching behavior were corroborated by local cytokine levels in ear samples, particularly with the significant reduction in IL-1b, IL-4, TNFa, and TSLP secretion (Table 1) . IFNc secretion was not altered by BPA administration (Table 1 ). The number of helper T-cells (TH cells) in auricle LNs, and IL-4 and IFNc production in auricle LNs were also downregulated by exposure to BPA, but the change in TH cell number and IFNc production was not significant (Figs. 1C-E). There was no impact of BPA administration on total IgE level in serum ( Figure 1F ).
Respiratory Allergic Inflammation Was Significantly Exacerbated by BPA Administration
Although allergic skin inflammation was suppressed by exposure to BPA, allergic airway inflammation was upregulated by BPA administration. The score of red coloration in the lung was significantly increased by exposure to BPA compared with that in the control group (Figure 2A) , and this was corroborated by the significant induction of eosinophils into the BALF ( Figure 2B ). The cytokine levels in the lung were also increased by BPA administration, and significant increases in IL-1b, IL-4, IL-33, TNFa, and TSLP were observed in the BPA-treated groups (Table 2) . Typical TH1 type cytokine IFNc was not influenced by BPA administration (Table 2) . TH cell number and IL-4 production in hilar LNs were simultaneously induced by exposure to BPA compared with those in the vehicle controls (Figs. 2C and  2D ). BPA administration also enhanced IFNc production, but the change was not significant ( Figure 1E ). Interestingly, total IgE level in serum was also altered by BPA administration, although the change was not significant ( Figure 2F ).
Preexposure to BPA Significantly Induced Cytokine Production From Human Bronchial Epithelial Cells, but Not From HEKs
Anti or proinflammatory responses observed in the in vivo studies were confirmed by in vitro experiments with HEKs and was significantly inhibited by oral exposure to BPA. B, Scratching behavior was also decreased by administration of BPA. C, Helper T-cell infiltration in auricular LNs was correspondingly reduced by BPA administration. D, Significant increase in IL-4 production (pg/ml) in auricle LNs supported the pro-inflammatory response to BPA exposure. E, IFNc production (pg/ml) in auricle LNs was also increased by BPA exposure but the change was not significant. F, Total IgE levels (pg/ml) in serum were not altered by BPA exposure. All results are represented as mean 6 SEM, n ¼ 5 in each group. *p < .05, **p < .01 (Dunnett's multiple comparison test) versus vehicle-only control group.
BEAS-2B cells. Although TNFa production from HEKs was not influenced by exposure to BPA, IL-8 production from BEAS-2B cells was significantly induced by exposure to BPA (Figs. 3A and  3C ). Comparable upregulation of TSLP gene expression in BEAS-2B cells was found in the BPA-treated groups ( Figure 3D ). On the other hand, TSLP gene expression in HEKs was significantly downregulated by BPA exposure ( Figure 3B ).
No Impact of BPA Exposure on Cytokine Release From DCs and Proliferation of T-Cells
Murine BMDCs and T-cells, which play important roles in the development of allergic inflammation, were analyzed in vitro as the next step. When BMDCs were exposed to BPA for 24 h followed by LPS stimulation, the release of IL-12 was comparable with that of the vehicle control group ( Figure 4A ). T-cell proliferation was measured by a mixed leukocyte reaction assay after cells were exposed to BPA. As observed in the BMDC assay, BPA exposure had no impact on T-cell proliferation ( Figure 4B ).
DISCUSSION
This study demonstrated three crucial aspects: (1) oral administration of BPA directly exacerbated TDI-induced respiratory allergic inflammation in mice, whereas skin inflammatory potential in the TDI-induced allergic dermatitis model was slightly interfered by oral administration of BPA; (2) in vitro experiments with HEKs and BEAS-2B cells supported the pro and antiinflammatory responses observed in vivo; and (3) DCs and T-cells might not be involved in pro and antiinflammatory responses by oral administration of BPA. Initially, we performed in vivo experiments using established TDI-induced allergic models to identify whether oral BPA administration alters allergic reaction. As all previous studies focused on the off-target effects of BPA, the present study investigated the direct impact of BPA administration on allergic inflammation and itch behavior. Mice were subjected to oral administration of BPA right before the final TDI challenge. Thus, the direct relationship between allergic response and BPA 158 6 21 246 6 20 184 6 10* 189 6 15* TSLP (pg/mg protein) 20 6 3 6 2 6 2 4 6 6 3** 50 6 4* IFN-c (pg/mg protein) 34 6 4 3 0 6 1 2 8 6 3 2 9 6 3
Ear sample was collected 24 h after TDI challenge. Results are expressed as mean 6 SEM, n ¼ 5 per group. *p < .05 and **p < .01 (Dunnett's multiple comparison test) versus TDI þ vehicle control group.
Figure 2. Oral administration of BPA exacerbates allergic airway inflammation in a mouse model of allergic airway inflammation. A, Dose-dependent significant increase was observed in scoring of red color in the lung. Grade was determined by semi-quantitative examination (0 ¼ no visible changes, 1 ¼ diffuse or patchy red coloration, 2 ¼ moderate dispersed red coloration, 3 ¼ severe red coloration). B, Eosinophil infiltration in BALF was also induced by oral administration of BPA in a dosedependent manner. C, Comparable induction of helper T-cell infiltration was observed in hilar LNs. D, Significant increase in IL-4 production (pg/ml) in hilar LNs supported the proinflammatory response to BPA exposure. E, IFNc production (pg/ml) in hilar LNs was also decreased by BPA exposure but the change was not significant. F, Total IgE levels (pg/ml) in serum were exacerbated by BPA exposure, although the response was not significant. All results are represented as mean 6 SEM, n ¼ 5 in each group. *p < .05, **p < .01 (Dunnett's multiple comparison test) versus vehicle-only control group.
exposure could be elucidated. To compare the different types of allergies, the allergic airway inflammation model and allergic dermatitis model were taken into consideration in this study. As a result, allergic airway inflammation was significantly upregulated by BPA exposure, with signs such as red coloration of the lung, increased number of eosinophils in the BALF, and increased secretion of proinflammatory cytokines (IL-1b, IL-4, IL-33, TSLP, and TNFa) in lung tissues ( Figure 2 and Table 2 ). These responses were corroborated by significant induction of TH cells and cytokine release from hilar LNs (Figure 2) . However, the opposite results were found in the TDI-induced allergic dermatitis model, such as decreased ear swelling responses and proinflammatory cytokine levels in the skin tissues (IL-1b, IL-4, TSLP, and TNFa) by exposure to BPA (Figure 1 and Table 1 ). Interestingly, itch behavior was also reduced by administration of BPA, although the response was not significant. Liu et al. (2016) and Wilson et al. (2013) recently demonstrated that TSLP and IL-33 evoked itch behavior via activation of pruritic receptors on peripheral neurons in dorsal root ganglia. Thus, the reduction of TSLP and IL-33 secretion in skin tissue possibly influenced the itch behavior. Comparable results were observed in TH cell number and cytokine secretion in auricular LNs (Figure 1 ). Several previous reports (Kim et al., 2017; Wang et al., 2016) have implied that BPA exposure and development of skin allergy were correlated with each other. However, the correlation might be attributed to the off-target effects of BPA exposure based on the above results.
In the next step, we performed in vitro studies to see whether activated keratinocytes, bronchial epithelial cells, and immune cells produced lower levels of cytokines or exhibited changes in 13 6 2 4 9 6 4 6 0 6 8 111 6 5** IFN-c (pg/mg protein) 12 6 1 2 7 6 4 3 3 6 3 2 8 6 4
Lung sample was isolated 24 h after TDI challenge. Results are expressed as mean 6 SEM, n ¼ 5 per group. *p < .05 and **p < .01 (Dunnett's multiple comparison test) versus TDI þ vehicle control group. (2010) reported that the immunomodulatory action in T-cell of miltefosine using TDI-induced allergic dermatitis model and mixed leukocyte reaction assay. Thus, we can at least partly predict the effect of immunomodulatory substances by inhibition or activation of keratinocytes, epithelial cells, and DCs as well as T-cell functions. Activation of HEKs with the toll-like receptor agonist poly (I:C) induced TNFa production and TSLP gene expression, which are related to itch behavior (Wilson et al., 2013) . We observed a slight dose-dependent inhibition for both TNFa and TSLP (Figure 3 ). On the other hand, activation of BEAS-2B cells with the toll-like receptor agonist LPS induced IL-8 production and TSLP gene expression, which are associated with airway inflammation and coughing (Gon and Hashimoto, 2018; Russo et al., 2014; Shi et al., 2017; Tang et al., 2011) . We observed an upregulation of both IL-8 and TSLP that corresponded to the in vivo evidence (Figure 3) . LPS also induced cytokine production in BMDCs, but interestingly we did not see any changes in IL-12 with BPA exposure (Figure 4 ). In addition, we evaluated the proliferation of T-cells in the mixed leukocyte reaction (Figure 4 ) and found that BPA exposure had almost no impact on T-cell proliferation.
Our findings implied that oral administration of BPA is directly associated with allergic inflammatory diseases. However, the profiles of allergic response to BPA administration are different depending on the type of allergy. Our results demonstrate the ability of BPA to significantly reduce cytokine response from keratinocytes in vitro (Figure 3 ) and reduce skin allergic inflammatory response in a TH2 allergen model (Figure 1) . Interestingly, an opposite response to the airway allergic model was observed in IL1-b, IL-4, IL-33, TNFa, and TSLP, a group of cytokines involved in inflammation processes in the respiratory tract (Tables 1 and 2 ). It is not clear why such strong upregulation of these cytokines was observed only in the in vivo model of allergic airway inflammation. However, it is possible that bronchial epithelial cells and TSLP, which have the potential to activate antigen-presenting cells and TH cells could play important roles based on our in vivo and in vitro results.
This study focuses on the acute and direct effect of BPA subjecting to oral administration of BPA at 48, 24, and 4 h before challenge with TDI; then it becomes important to determine if the effect is reversible. According to the pharmacokinetics data of BPA in orally administered adult CD-1 mice by Doerge et al. (2011) , oral administration of BPA gave rise to a rapid absorption phase (T max :30 min) with similar distribution kinetics for unconjugated and total BPA. A rapid absorption phase was followed by the distribution phase (2-to 6-h postoral dosing) and a slower elimination phases for both unconjugated and total BPA until probably 48-h postdosing. These evidences indicate that; (1) our schedule to detect the direct effect of BPA on allergic inflammation was appropriate, (2) "direct" effect of BPA on inflammatory response may not prolong for a long time and it should be reversible. However, accurate evidence is needed to be exhibited in future studies.
In future studies, it would be beneficial to continue characterizing the inflammatory and pruritic potentials of BPA and other types of endocrine disruptors. Evaluating both parameters in chronic models of allergy such as NC/Nga mice would be useful to determine the inflammatory and pruritogenic mechanisms further.
